Skip to main content
OpenTrials
Completed

NCT Number: NCT02905851

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acne Vulgaris Acneiform Eruptions Sebaceous Gland Diseases Skin Diseases Skin and Connective Tissue Diseases

Age range

15 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UC Davis Department of Dermatology, Clinical Trials Unit

Sacramento, California, 95816, United States

About this study

The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use.

There are two arms of the study:

  • Feedback group
  • Non feedback group

All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months).

The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects aged 15 years and older
  • Subjects who have been prescribed doxycycline or minocycline by their physician for acne vulgaris but have not initiated treatment yet.

Exclusion criteria

  • Subjects who have used isotretinoin in the last 6 weeks
  • Those who have used oral antibiotics within the last 4 weeks
  • Those who have been initiated or changed brand of oral contraceptive pill within the last one month.
  • Those subjects who cannot engage with the teledermatology platform
  • Prisoners
  • Adults unable to consent

Treatment and study plan

Feedback Group

Other

Monitoring ability to use teledermatology to modify antibiotic burden

Non Feedback group

Other

To use as control to see if antibiotic burden has been reduced in the active feedback group

Primary outcomes

  1. Reduced antibiotic use

    Time frame: Assessed at 4, 8, 12 weeks

    The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback

Other outcomes

  1. Change in acne grading (change in patient grading)

    Time frame: Assessed at 4, 8, 12 weeks

    Change in Patient Grading

  2. Change in acne grading (investigator global assessment)

    Time frame: Assessed at 4, 8, 12 weeks

    Change in Investigator Global Assessment

  3. Change in acne grading (lesion counting)

    Time frame: Assessed at 4, 8, 12 weeks

    Change in Lesion Counting

  4. Change in acne grading using the global acne grading

    Time frame: Assessed at 4, 8, 12 weeks

    Change in Global Acne Grading

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Sep 19, 2016
Registry last updated
Jul 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.